This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pulukuri, S. M. K. Articles by Rao, J. S. Search for Related Content PubMed PubMed Citation Articles by Pulukuri, S. M. K. Articles by Rao, J. S.

Small Interfering RNA–Directed Reversal of Urokinase Plasminogen Activator Demethylation Inhibits Prostate Tumor Growth and Metastasis

Departments of ¹ Cancer Biology and Pharmacology and ² Neurosurgery, University of Illinois College of Medicine at Peoria, Peoria, Illinois

Requests for reprints: Jasti S. Rao, Program of Cancer Biology, University of Illinois College of Medicine, One Illini Drive, Peoria, IL 61605. Phone: 309-671-3445; Fax: 309-671-3442; E-mail: jsrao{at}uic.edu.

Recent studies have shown that small interfering RNA (siRNA) silences genes at the transcriptional level in human cells. However, the therapeutic potential of siRNA-mediated transcriptional gene silencing remains unclear. Here, we show that siRNA targeted to the urokinase plasminogen activator (uPA) promoter induced epigenetic transcriptional silencing in human prostate cancer cells. This silencing resulted in a dramatic reduction of tumor cell invasion and angiogenesis in vitro. Furthermore, the results from a bioluminescence tumor/metastasis model showed that the silencing of uPA significantly inhibits prostate tumor growth and the incidence of lung metastasis. Our findings represent a potentially powerful new approach to not only epigenetic silencing of metastasis or growth-promoting genes as a cancer therapy, but also as a means to shed light on how aberrant de novo methylation during cancer progression might be targeted to specific sequences. [Cancer Res 2007;67(14):6637–46]

This article has been cited by other articles:

				E. M. Conn, K. A. Botkjaer, T. A. Kupriyanova, P. A. Andreasen, E. I. Deryugina, and J. P. Quigley Comparative Analysis of Metastasis Variants Derived from Human Prostate Carcinoma Cells: Roles in Intravasation of VEGF-Mediated Angiogenesis and uPA-Mediated Invasion Am. J. Pathol., October 1, 2009; 175(4): 1638 - 1652. [Abstract] [Full Text] [PDF]

				G Feldmann, N Habbe, S Dhara, S Bisht, H Alvarez, V Fendrich, R Beaty, M Mullendore, C Karikari, N Bardeesy, et al. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer Gut, October 1, 2008; 57(10): 1420 - 1430. [Abstract] [Full Text] [PDF]

				K. Suzuki, T. Juelich, H. Lim, T. Ishida, T. Watanebe, D. A. Cooper, S. Rao, and A. D. Kelleher Closed Chromatin Architecture Is Induced by an RNA Duplex Targeting the HIV-1 Promoter Region J. Biol. Chem., August 22, 2008; 283(34): 23353 - 23363. [Abstract] [Full Text] [PDF]

				C.-W. Lin, S.-C. Shen, W.-C. Hou, L.-Y. Yang, and Y.-C. Chen Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9 Mol. Cancer Ther., May 1, 2008; 7(5): 1195 - 1206. [Abstract] [Full Text] [PDF]

				M. S. Weinberg, S. Barichievy, L. Schaffer, J. Han, and K. V. Morris An RNA targeted to the HIV-1 LTR promoter modulates indiscriminate off-target gene activation Nucleic Acids Res., December 18, 2007; 35(21): 7303 - 7312. [Abstract] [Full Text] [PDF]